-
Je něco špatně v tomto záznamu ?
May circulating steroids reveal a predisposition to intrahepatic cholestasis of pregnancy in non-pregnant women
P. Šimják, M. Hill, A. Pařízek, L. Vítek, M. Velíková, M. Dušková, R. Kancheva, J. Bulant, M. Koucký, Z. Kokrdová, K. Adamcová, A. Černý, Z. Hájek, L. Stárka
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- biologické markery krev MeSH
- dospělí MeSH
- genetická predispozice k nemoci genetika MeSH
- intrahepatální cholestáza krev diagnóza genetika MeSH
- jaterní testy trendy MeSH
- komplikace těhotenství krev diagnóza genetika MeSH
- lidé MeSH
- placentární oběh fyziologie MeSH
- steroidy krev MeSH
- těhotenství MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Intrahepatic cholestasis of pregnancy (ICP) is a frequent liver disorder, mostly occurring in the third trimester. ICP is not harmful to the mothers but threatens the fetus. The authors evaluated steroid alterations in maternal and mixed umbilical blood to elucidate their role in the ICP development. Ten women with ICP were included in the study. Steroids in the maternal blood were measured by Gas Chromatography-Mass Spectrometry (GC-MS) (n=58) and RIA (n=5) at the diagnosis of ICP, labor, day 5 postpartum, week 3 postpartum and week 6 postpartum. The results were evaluated by ANOVA consisting of the subject factor, between subject factors ICP, gestational age at the diagnosis of ICP and gestational age at labor, within-subject factor Stage and ICP × Stage interaction. The 17 controls were firstly examined in the week 36 of gestation. ICP patients showed reduced CYP17A1 activity in the C17,20 lyase step thus shifting the balance between the toxic conjugated pregnanediols and harmless sulfated 5alpha/beta-reduced-17-oxo C19 steroids. Hence, more toxic metabolites originating in maternal liver from the placental pregnanes may penetrate backward to the fetal circulation. As these alterations persist in puerperium, the circulating steroids could be potentially used for predicting the predisposition to ICP even before next pregnancy.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19005356
- 003
- CZ-PrNML
- 005
- 20210602141457.0
- 007
- ta
- 008
- 190204s2018 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934028 $2 doi
- 035 __
- $a (PubMed)30484676
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Šimják, Patrik $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic $7 xx0221733
- 245 10
- $a May circulating steroids reveal a predisposition to intrahepatic cholestasis of pregnancy in non-pregnant women / $c P. Šimják, M. Hill, A. Pařízek, L. Vítek, M. Velíková, M. Dušková, R. Kancheva, J. Bulant, M. Koucký, Z. Kokrdová, K. Adamcová, A. Černý, Z. Hájek, L. Stárka
- 520 9_
- $a Intrahepatic cholestasis of pregnancy (ICP) is a frequent liver disorder, mostly occurring in the third trimester. ICP is not harmful to the mothers but threatens the fetus. The authors evaluated steroid alterations in maternal and mixed umbilical blood to elucidate their role in the ICP development. Ten women with ICP were included in the study. Steroids in the maternal blood were measured by Gas Chromatography-Mass Spectrometry (GC-MS) (n=58) and RIA (n=5) at the diagnosis of ICP, labor, day 5 postpartum, week 3 postpartum and week 6 postpartum. The results were evaluated by ANOVA consisting of the subject factor, between subject factors ICP, gestational age at the diagnosis of ICP and gestational age at labor, within-subject factor Stage and ICP × Stage interaction. The 17 controls were firstly examined in the week 36 of gestation. ICP patients showed reduced CYP17A1 activity in the C17,20 lyase step thus shifting the balance between the toxic conjugated pregnanediols and harmless sulfated 5alpha/beta-reduced-17-oxo C19 steroids. Hence, more toxic metabolites originating in maternal liver from the placental pregnanes may penetrate backward to the fetal circulation. As these alterations persist in puerperium, the circulating steroids could be potentially used for predicting the predisposition to ICP even before next pregnancy.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a intrahepatální cholestáza $x krev $x diagnóza $x genetika $7 D002780
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetická predispozice k nemoci $x genetika $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a jaterní testy $x trendy $7 D008111
- 650 _2
- $a placentární oběh $x fyziologie $7 D021041
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a komplikace těhotenství $x krev $x diagnóza $x genetika $7 D011248
- 650 _2
- $a steroidy $x krev $7 D013256
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hill, Martin, $d 1962- $7 mzk2005304431 $u Institute of Endocrinology, Prague, CzechRepublic
- 700 1_
- $a Pařízek, Antonín, $d 1959- $7 mzk2005294935 $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Vítek, Libor, $d 1969- $7 xx0035071 $u Institute of Medical Biochemistry and Laboratory Diagnostics and Fourth Department ofInternal Medicine, General University Hospital and First Faculty of Medicine of Charles Universityin Prague, Czech Republic
- 700 1_
- $a Velíková, Marta $7 xx0209755 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Dušková, Michaela $7 xx0080454 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Kantcheva, Radmila $7 xx0102173 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Bulant, Josef $7 xx0207735 $u Institute of Endocrinology, Prague, Czech Republic; Department of Pediatrics and Adolescent Medicine, General UniversityHospital and First Faculty of Medicine of Charles University in Prague, Czech Republic
- 700 1_
- $a Koucký, Michal $7 xx0107050 $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Kokrdová, Zuzana $7 xx0108022 $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Adamcová, Karolína $7 xx0222599 $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Černý, Andrej $7 xx0232894 $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Hájek, Zdeněk, $d 1943- $7 skuk0000531 $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Stárka, Luboslav, $d 1930- $7 jn19990209795 $u Institute of Endocrinology, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 67, Suppl. 3 (2018), s. S499-S510
- 773 0_
- $t Dr. Karel Šilink - The 110th anniversary of the birth $g (2018), s. S499-S510 $w MED00206981
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30484676 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20190204 $b ABA008
- 991 __
- $a 20210602141455 $b ABA008
- 999 __
- $a ok $b bmc $g 1377929 $s 1043561
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 67 $c Suppl. 3 $d S499-S510 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- BMC __
- $a 2018 $d S499-S510 $m Dr. Karel Šilink - The 110th anniversary of the birth $x MED00206981
- LZP __
- $b NLK118 $a Pubmed-20190204